Health Care & Life Sciences » Medical Equipment & Supplies | Medite Cancer Diagnostics Inc.

Medite Cancer Diagnostics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
1.00
230.00
587.00
108.00
490.00
Total Accounts Receivable
10.00
1,991.00
1,798.00
1,346.00
453.00
Inventories
-
3,415.00
3,075.00
3,811.00
2,403.00
Other Current Assets
5.00
154.00
186.00
79.00
118.00
Total Current Assets
16.00
5,790.00
5,646.00
5,344.00
3,464.00
Net Property, Plant & Equipment
5.00
2,091.00
1,941.00
1,557.00
1,778.00
Long-Term Note Receivable
-
-
-
25.00
-
Intangible Assets
-
10,518.00
10,518.00
10,518.00
10,518.00
Other Assets
-
245.00
273.00
151.00
196.00
Total Assets
21.00
18,644.00
18,378.00
17,545.00
15,956.00
ST Debt & Current Portion LT Debt
121.00
2,665.00
3,129.00
3,895.00
480.20
Accounts Payable
311.00
956.00
652.00
1,127.00
1,004.00
Other Current Liabilities
3,861.00
3,178.00
2,380.00
2,325.00
2,297.80
Total Current Liabilities
4,293.00
6,799.00
6,161.00
7,347.00
3,782.00
Long-Term Debt
-
1,209.00
846.00
195.00
4,914.00
Deferred Taxes
-
2,205.00
2,205.00
2,005.00
1,485.00
Total Liabilities
4,293.00
10,213.00
9,212.00
9,547.00
10,181.00
Common Equity (Total)
5,759.00
6,944.00
8,204.00
7,036.00
4,813.00
Total Shareholders' Equity
4,272.00
8,431.00
9,166.00
7,998.00
5,775.00
Total Equity
4,272.00
8,431.00
9,166.00
7,998.00
5,775.00
Liabilities & Shareholders' Equity
21.00
18,644.00
18,378.00
17,545.00
15,956.00
Preferred Stock (Carrying Value)
1,487.00
1,487.00
962.00
962.00
962.00

About Medite Cancer Diagnostics

View Profile
Address
4203 SW 34th Street
Orlando Florida 32811
United States
Employees -
Website http://www.medite-group.com
Updated 07/08/2019
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. It specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland.